-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, J5Sx5R2cd3i72Ps+Yv2Jfbkycv3SqcuHr3T5Y9Wffwlavc3wRdiaM2SHXllOLn6i Q2RDubrqNwesEhSwCujvpw== 0001179110-08-005610.txt : 20080311 0001179110-08-005610.hdr.sgml : 20080311 20080311165237 ACCESSION NUMBER: 0001179110-08-005610 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080307 FILED AS OF DATE: 20080311 DATE AS OF CHANGE: 20080311 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVANT IMMUNOTHERAPEUTICS INC CENTRAL INDEX KEY: 0000744218 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 133191702 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 02494 BUSINESS PHONE: 7814330771 MAIL ADDRESS: STREET 1: 119 FOURTH AVE CITY: NEEDHAM STATE: MA ZIP: 021942725 FORMER COMPANY: FORMER CONFORMED NAME: T CELL SCIENCES INC DATE OF NAME CHANGE: 19920703 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: FREEMAN PAULA R CENTRAL INDEX KEY: 0001260290 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-15006 FILM NUMBER: 08681121 MAIL ADDRESS: STREET 1: 33 WHISPER DRIVE CITY: WORCESTER STATE: MA ZIP: 01748 4 1 edgar.xml FORM 4 - X0202 4 2008-03-07 1 0000744218 AVANT IMMUNOTHERAPEUTICS INC AVAN 0001260290 FREEMAN PAULA R 33 WHISPER DRIVE WORCESTER MA 01609 0 0 0 1 Sr.Dir.Human Resources Incentive Stock Option 8.16 2008-03-07 4 A 0 11250 8.16 A 2015-03-07 Common Stock 11250 11250 D Incentive Stock Option 20.06 2008-03-07 4 M 0 754 20.06 A 2002-12-09 2008-12-09 Common Stock 754 754 D This option was granted for 135,000 shares at an exercise price of $0.68 per share, but was adjusted to reflect the one-for-twelve reverse stock split that occurred on March 7, 2008. 25% of the shares vest annually over the first four years. 98,000 options granted under the AVANT 1999 Stock Option and Incentive Plan were cancelled according to their terms for no consideration on March 7, 2008. This option was previously reported as covering 9,050 shares at an exercise price of $1.672 per share, but was adjusted to reflect the one-for-twelve reverse stock split that occurred on March 7, 2008. Paula R. Freeman 2008-03-11 -----END PRIVACY-ENHANCED MESSAGE-----